Therefore, in this study, we hypothesized that the receptor of PSGL-1 (P-selectin) is highly and specifically expressed on the endothelium in the vicinity of MM cells, which can be used as a unique target for specific drug delivery to the tumor area. This evidence concerns the gene SELP and Miyoshi myopathy.